SCHOTT Pharma AG & Co. KGaA (SHTPY)
4.37
0.00 (0.00%)
USD |
OTCM |
May 15, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 658.19M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -31.96% |
| Valuation | |
| PE Ratio | 15.89 |
| PE Ratio (Forward) | |
| PS Ratio | 2.290 |
| Price to Book Value | 0.6063 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.0526 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.00 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| SCHOTT Pharma AG & Co. KgaA engages in the provision of designing drug containment and drug delivery solutions. It operates through the Drug Containment Solutions and Drug Delivery Systems segments. The Drug Containment Solutions segment focuses on the products from the Core category that currently make up the largest part of the DCS product portfolio. The Drug Delivery Systems segment includes products that are characterized by improved product functionality and belong to the HVS product portfolio. It offers a wide range of advanced drug containment solutions and delivery systems for inject able drugs that supply to the pharmaceutical and biotechnology industries. The company was founded on May 10, 2022 and is headquartered in Mainz, Germany. |
| URL | https://www.schott.com |
| Investor Relations URL | N/A |
| HQ State/Province | Rheinland-Pfalz |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Next Earnings Release | Aug. 12, 2026 |
| Last Earnings Release | May. 13, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Feb. 05, 2026 |
Profile
| SCHOTT Pharma AG & Co. KgaA engages in the provision of designing drug containment and drug delivery solutions. It operates through the Drug Containment Solutions and Drug Delivery Systems segments. The Drug Containment Solutions segment focuses on the products from the Core category that currently make up the largest part of the DCS product portfolio. The Drug Delivery Systems segment includes products that are characterized by improved product functionality and belong to the HVS product portfolio. It offers a wide range of advanced drug containment solutions and delivery systems for inject able drugs that supply to the pharmaceutical and biotechnology industries. The company was founded on May 10, 2022 and is headquartered in Mainz, Germany. |
| URL | https://www.schott.com |
| Investor Relations URL | N/A |
| HQ State/Province | Rheinland-Pfalz |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Next Earnings Release | Aug. 12, 2026 |
| Last Earnings Release | May. 13, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Feb. 05, 2026 |